Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: Neurogastroenterol Motil. 2015 Dec 20;28(4):513–521. doi: 10.1111/nmo.12745

Table 2.

Characteristics of Four GERD Phenotypes from pH-Impedance Monitoring on PPI

Strong Reflux
Evidence
n=6
Good Reflux
Evidence
n=17
Reflux
Hypersensitivity
n=24
Equivocal or No
Reflux Evidence
n=46
p values
Mean age (yr) 47.2±2.5 51.4±2.5 58.5±2.0 53.0±2.1 0.104
Gender (F) 5 (83.3%) 12 (70.6%) 19 (79.2%) 33 (71.7%) 0.842
Race (Caucasian) 6 (100%) 13 (76.5%) 22 (91.7%) 36 (78.3%) 0.616
Typical symptoms* 5 (83.3%) 10 (58.8%) 15 (62.5%) 24 (52.2%) 0.489
Duration of follow-up (mo) 32.3±3.8 42.2±3.5 44.1±4.3 42.3±2.6 0.553
Surgical Treatment 4 (66.7%) 8 (47.1%) 7 (29.2%) 5 (10.9%) 0.002
DSI
  Baseline 14.0±2.0 8.3±1.2 9.4±1.2 7.6±0.9 0.061
  Change** 7.2±4.0 4.5±1.5 6.2±1.3 3.5±0.9 0.306
  Follow-up 6.8±3.2 3.8±1.1 3.2±1.0 4.1±0.7 0.491
  ≥50% Improvement 3 (50.0%) 10 (62.5%) 17 (77.3%) 26 (61.9%) 0.518
GSS
  Baseline 74.3±8.7 66.1±5.3 61.9±6.2 58.1±3.9 0.421
  Change** 40.2±14.5 38.7±8.9 36.0±7.7 19.4±3.7 0.057
  Follow-up 34.2±11.6 27.4±6.5 23.0±6.0 37.7±4.2 0.194
  ≥50% Improvement 3 (50.0%) 12 (70.6%) 11 (55.0%) 13 (29.5%) 0.022

PPI: proton pump inhibitor; DSI: dominant symptom intensity; GSS: global symptom severity

*

heartburn, acid regurgitation

**

between baseline and follow-up assessments

ANOVA for continuous variables, chi-square for categorical variables